Ochola Rachel
School of Health, Department of Biomedical Sciences, Technical University of Kenya, Nairobi P.O. Box 52428-00200, Kenya.
Trop Med Infect Dis. 2025 May 8;10(5):129. doi: 10.3390/tropicalmed10050129.
Sub-Saharan Africa has made remarkable strides in genomic surveillance, with more than 50% of countries now equipped with an in-country sequencing capacity and 98% actively contributing data to public genomic repositories. Catalyzed by the momentum of the COVID-19 pandemic, these advancements have extended far beyond SARS-CoV-2 to address a broader spectrum of public health threats, including antimicrobial resistance (AMR) and other emerging infectious diseases. This review explores these transformative achievements, identifies remaining gaps, and outlines strategic priorities for embedding genomics into the continent's health systems. With a focus on sustainability, equity, and cross-sector collaboration, it positions Africa as a driver of global innovation in pathogen surveillance, uniquely leveraging its genetic and epidemiological diversity.
撒哈拉以南非洲在基因组监测方面取得了显著进展，目前超过50%的国家具备国内测序能力，98%的国家积极向公共基因组数据库贡献数据。在新冠疫情的推动下，这些进展已远远超出了严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的范畴，以应对更广泛的公共卫生威胁，包括抗菌药物耐药性（AMR）和其他新发传染病。本综述探讨了这些变革性成就，找出了尚存的差距，并概述了将基因组学融入非洲大陆卫生系统的战略重点。它以可持续性、公平性和跨部门合作为重点，将非洲定位为全球病原体监测创新的推动者，独特地利用其遗传和流行病学多样性。
